Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 875 of 1463 entries
View as:

Early Specialized Cardiovascular Intervention Based on Impedance Cardiography in Locally Advanced Non-small Cell Lung Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT04980716 Org: User:
Start: 06/01/21 End: 07/01/26 Due: 07/01/27

Sorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCC

Phase: N/A Priority: Normal
NCT ID: NCT02774187 Org: User:
Start: 05/31/16 End: 08/31/18 Due: 08/31/19

Concurrent Chemoradiotherapy With Nedaplatin Versus Cisplatin in Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01540136 Org: User:
Start: 02/29/12 End: 07/31/16 Due: 07/31/17

An Open-label, Multicentre, Phase II/III RCT of PFLL Versus GP Combined With JS001 as the First-line Therapy for mNPC

Phase: N/A Priority: Normal
NCT ID: NCT04890522 Org: User:
Start: 07/01/21 End: 12/31/28 Due: 12/31/29

A Study of Combination of Anti-PD1 Antibody-activated TILs and Chemotherapy in Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03904537 Org: User:
Start: 02/19/19 End: 12/31/21 Due: 12/31/22

The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Beyond Milan Criteria BCLC Stage A/B Hepatocellular Carcinoma Who Underwent Hepatectomy

Phase: N/A Priority: Normal
NCT ID: NCT03851913 Org: User:
Start: 07/01/18 End: 08/31/24 Due: 08/31/25

Once-daily Simultaneous Modulated Accelerated Thoracic Radiotherapy in Limited Small-cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02337712 Org: User:
Start: 01/31/15 End: 12/31/21 Due: 12/31/22

A National School-based Health Lifestyles Interventions Among Chinese Children and Adolescents Against Obesity

Phase: N/A Priority: Normal
NCT ID: NCT02343588 Org: User:
Start: 09/30/13 End: 01/31/15 Due: 01/31/16

Trastuzumab Combined With Chemotherapy or Endocrine Therapy to Treat Metastatic Luminal B2 Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01950182 Org: User:
Start: 09/16/13 End: 05/31/20 Due: 05/31/21

Association of Haptoglobin 2-2 With Postoperative Delirium

Phase: N/A Priority: Normal
NCT ID: NCT03392480 Org: User:
Start: 12/20/17 End: 12/30/19 Due: 12/30/20

Phase II Study of Irinotecan Liposome (II) Combined With Temozolomide and Fluzoparib in Recurrent or Metastatic Ewing Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT06827717 Org: User:
Start: 04/15/25 End: 02/29/28 Due: 02/28/29

Prognostic Analysis of Concurrent Chemoradiotherapy With/Without Adjuvant Chemotherapy for Locally Advanced NPC Patients

Phase: N/A Priority: Normal
NCT ID: NCT02973386 Org: User:
Start: 01/31/17 End: 12/31/25 Due: 12/31/26

QL1706 in the Treatment of Advanced Bone and Soft Tissue Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT06939855 Org: User:
Start: 06/30/25 End: 05/01/28 Due: 05/01/29

Phase II Trial of Neoadjuvant and Adjuvant Anti-PD-1 Antibody Toripalimab Combined With CCRT in NPC Patients

Phase: N/A Priority: Normal
NCT ID: NCT03925090 Org: User:
Start: 12/08/19 End: 10/31/23 Due: 10/31/24

IMRT With Carboplatin Versus IMRT With Carboplatin and Fluorouracil for Eldly Esophageal Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT03910634 Org: User:
Start: 04/09/19 End: 12/31/21 Due: 12/31/22

Toripalimab Combined With CAV/IE Regimen

Phase: N/A Priority: Normal
NCT ID: NCT04589741 Org: User:
Start: 10/23/20 End: 06/30/26 Due: 06/30/27

Modified Orbital Decompression in the Treatment of Moderate-to-severe Grave's Ophthalmopathy

Phase: N/A Priority: Normal
NCT ID: NCT06588764 Org: User:
Start: 09/30/24 End: 01/31/26 Due: 01/31/27

Promoting Atrial Fibrillation Screening in Primary Care

Phase: N/A Priority: Normal
NCT ID: NCT06458829 Org: User:
Start: 07/01/24 End: 12/30/26 Due: 12/30/27

Hetrombopag in Secondary Prevention of XPO-1 Inhibitor-induced Thrombocytopenia in Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT05969158 Org: User:
Start: 09/04/23 End: 08/01/25 Due: 08/01/26

Ensartinib in Combination With Bevacizumab in ALK-positive NSCLC Patients With TP53 Mutation

Phase: N/A Priority: Normal
NCT ID: NCT05491811 Org: User:
Start: 08/01/22 End: 12/31/26 Due: 12/31/27

Neoadjuvant Chemotherapy + Surgery Versus Surgery in FIGO IB2 and IIA2 Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02629718 Org: User:
Start: 12/31/15 End: 12/31/22 Due: 12/31/23

Efficacy of Capecitabine Metronomic Chemotherapy to Triple-negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01112826 Org: User:
Start: 04/23/10 End: 12/31/19 Due: 12/31/20

Surufatinib Combined With TAS-102 in Third-line and Later-line Therapy of Patients With Advanced Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05481463 Org: User:
Start: 01/30/23 End: 05/10/25 Due: 05/10/26

Study of Toripalimab for Limited-Stage Small Cell Lung Cancer Following Concurrent Chemoradiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT04418648 Org: User:
Start: 06/01/20 End: 05/31/24 Due: 05/31/25

The Study of Clinical Value of Acute Physiologic and Chronic Health Evaluation (APACHE) Scoring System in Medical Intensive Care Unit

Phase: N/A Priority: Normal
NCT ID: NCT01162408 Org: User:
Start: 07/31/10 End: - Due: -